Linked Life Data

15154660

Source:http://linkedlifedata.com/resource/pubmed/id/15154660

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2C
pubmed:dateCreated
2004-5-24
pubmed:abstractText
Fulvestrant ('Faslodex') is a new type of oestrogen receptor (ER) antagonist that down-regulates the ER and has no known agonist effects.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0250-7005
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1275-80
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:articleTitle
Fulvestrant for the treatment of advanced breast cancer in postmenopausal women: a Japanese study.
pubmed:affiliation
National Cancer Centre Hospital, 5-1-i, Tsukiji, Chuo-ku, Tokyo, Japan. watanabe-oncology@iuhw.ac.jp
pubmed:publicationType
Journal Article, Clinical Trial, Clinical Trial, Phase II